(Q30407654)

21 June 2017

1 reference

title

Immune responses to influenza virus infection (English)

1 reference

21 June 2017

3

G F Rimmelzwaan

1 reference

21 June 2017

J H C M Kreijtz

1

1 reference

PubMed ID

21963677

21 June 2017

R A M Fouchier

series ordinal

2

1 reference

21 June 2017

22 September 2011

1 reference

21 June 2017

1 reference

21 June 2017

162

1 reference

21 June 2017

1-2

1 reference

21 June 2017

19-30

1 reference

Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells

21 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Recognition of viral hemagglutinins by NKp44 but not by NKp30.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Fitness costs limit escape from cytotoxic T lymphocytes by influenza A viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Assessment of the extent of variation in influenza A virus cytotoxic T-lymphocyte epitopes by using virus-specific CD8+ T-cell clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

The loss of immunodominant epitopes affects interferon-gamma production and lytic activity of the human influenza virus-specific cytotoxic T lymphocyte response in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Yearly influenza vaccinations: a double-edged sword?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Vaccination with whole inactivated virus vaccine affects the induction of heterosubtypic immunity against influenza virus A/H5N1 and immunodominance of virus-specific CD8+ T-cell responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

A single immunization with CoVaccine HT-adjuvanted H5N1 influenza virus vaccine induces protective cellular and humoral immune responses in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

The magnitude and specificity of influenza A virus-specific cytotoxic T-lymphocyte responses in humans is related to HLA-A and -B phenotype.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Sequence variation in a newly identified HLA-B35-restricted epitope in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza A virus specific T cell immunity in humans during aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Recognition of homo- and heterosubtypic variants of influenza A viruses by human CD8+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Phenotypical and functional specialization of FOXP3+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

A single N66S mutation in the PB1-F2 protein of influenza A virus increases virulence by inhibiting the early interferon response in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Immunomodulatory therapy for severe influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Pathogenicity of highly pathogenic avian influenza virus in mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Granzyme A-deficient mice retain potent cell-mediated cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Antibody recognition of a highly conserved influenza virus epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

A highly conserved neutralizing epitope on group 2 influenza A viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Complement and natural antibody are required in the long-term memory response to influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Virus-specific CD8+ T cells in primary and secondary influenza pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Pandemic potential of a strain of influenza A (H1N1): early findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Maternal immunization to protect the mother and neonate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Prospects for universal influenza virus vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Division of labor between dendritic cell subsets of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Both conventional and interferon killer dendritic cells have antigen-presenting capacity during influenza virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Standardization and validation of assays determining cellular immune responses against influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Population dynamics of rapid fixation in cytotoxic T lymphocyte escape mutants of influenza A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

The PB2 subunit of the influenza virus RNA polymerase affects virulence by interacting with the mitochondrial antiviral signaling protein and inhibiting expression of beta interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Heterosubtypic immunity to influenza A virus: where do we stand?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Interaction of Hsp40 with influenza virus M2 protein: implications for PKR signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Immune correlates of protection against influenza: challenges for licensure of seasonal and pandemic influenza vaccines, Miami, FL, USA, March 1-3, 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Low-dose interferon Type I treatment is effective against H5N1 and swine-origin H1N1 influenza A viruses in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Cross-protective immunity against influenza pH1N1 2009 viruses induced by seasonal influenza A (H3N2) virus is mediated by virus-specific T-cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Induction of tolerance to innocuous inhaled antigen relies on a CCR7-dependent dendritic cell-mediated antigen transport to the bronchial lymph node

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza virus activates inflammasomes via its intracellular M2 ion channel

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza virus infection in the second and third trimesters of pregnancy: a clinical and seroepidemiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza A virus polymerase inhibits type I interferon induction by binding to interferon beta promoter stimulator 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Protective role for protease-activated receptor-2 against influenza virus pathogenesis via an IFN-gamma-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Alveolar macrophages are indispensable for controlling influenza viruses in lungs of pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Elevation of Cord over Maternal IgG Immunoglobulin: Evidence for an Active Placental IgG Transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Primary influenza A virus infection induces cross-protective immunity against a lethal infection with a heterosubtypic virus strain in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza A/H5N1 viruses at low doses and after single immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Regulation of antinucleoprotein IgG by systemic vaccination and its effect on influenza virus clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Use of viral vectors for the development of vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Recognition of single-stranded RNA viruses by Toll-like receptor 7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Immunosenescence: what does it mean to health outcomes in older adults?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

T cell responses are better correlates of vaccine protection in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Cytotoxic T-cell immunity to influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Human and mouse granzyme A induce a proinflammatory cytokine response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

A universal influenza A vaccine based on the extracellular domain of the M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Characterization of a fully human monoclonal antibody against extracellular domain of matrix protein 2 of influenza A virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Inflammasomes as mediators of immunity against influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Host response to influenza virus: protection versus immunopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Tumor necrosis factor as a mediator of inflammation in influenza A viral pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

The underrecognized burden of influenza in young children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Determinants of immunity to influenza infection in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Protection of infants from infection with influenza A virus by transplacentally acquired antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Observational study to investigate vertically acquired passive immunity in babies of mothers vaccinated against H1N1v during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

The development of inducible bronchus-associated lymphoid tissue depends on IL-17.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Cutting edge: rapid and efficient in vivo cytotoxicity by cytotoxic T cells is independent of granzymes A and B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Effect of passive maternal antibody on influenza illness in children: a prospective study of influenza A in mother-infant pairs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Attenuated influenza virus vaccines with modified NS1 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Functional compensation of a detrimental amino acid substitution in a cytotoxic-T-lymphocyte epitope of influenza a viruses by comutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Sequence variation in the influenza A virus nucleoprotein associated with escape from cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Full restoration of viral fitness by multiple compensatory co-mutations in the nucleoprotein of influenza A virus cytotoxic T-lymphocyte escape mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza virus serology--a comparative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Protective cross-reactive cellular immunity to lethal A/Goose/Guangdong/1/96-like H5N1 influenza virus is correlated with the proportion of pulmonary CD8(+) T cells expressing gamma interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza A virus nucleoprotein exploits Hsp40 to inhibit PKR activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Immuno-epidemiologic correlates of pandemic H1N1 surveillance observations: higher antibody and lower cell-mediated immune responses with advanced age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Avian Influenza A (H5N1) Age Distribution in Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Mapping the antigenic and genetic evolution of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Cytolytic CD4(+) T cells in viral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza virus-like particles containing M2 induce broadly cross protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza virus vaccine based on the conserved hemagglutinin stalk domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Differential effect of CD4+Foxp3+ T-regulatory cells on the B and T helper cell responses to influenza virus vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza A H5N1 replication sites in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

7 January 2021

Influenza DNA vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

FATT-CTL assay for detection of antigen-specific cell-mediated cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Transplacental transport of IgG antibodies to preterm infants: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

The costimulatory molecule CD27 maintains clonally diverse CD8(+) T cell responses of low antigen affinity to protect against viral variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Protection against a European H1N2 swine influenza virus in pigs previously infected with H1N1 and/or H3N2 subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

H5N1 Virus Attachment to Lower Respiratory Tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Highly pathogenic avian influenza virus H5N1 infects alveolar macrophages without virus production or excessive TNF-alpha induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Structural basis of immune recognition of influenza virus hemagglutinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

T cell memory in the lung airways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Transplacental antibody transfer following maternal immunization with a pandemic 2009 influenza A(H1N1) MF59-adjuvanted vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Mx proteins: mediators of innate resistance to RNA viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

Secretory and systemic immunological response in children infected with live attenuated influenza A virus vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2011.09.022

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIRUSRES.2011.09.022

1 reference

21 June 2017

1 reference

PubMed ID

21963677